These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 8395101

  • 1. Over-expression of c-myc oncoprotein in B lymphocytes of renal transplant recipients with lymphoproliferative disorders.
    Sabido O, Alamartine E, Barthelemy JC, Berthoux F.
    Transplantation; 1993 Aug; 56(2):467-70. PubMed ID: 8395101
    [No Abstract] [Full Text] [Related]

  • 2. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig.
    Schrader CE, Stavnezer J, Kikutani H, Parker DC.
    J Immunol; 1997 Jan 01; 158(1):153-62. PubMed ID: 8977186
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of c-myc protein in B and T lymphocytes.
    Lens D, Matutes E, Farahat N, Morilla R, Catovsky D.
    Leukemia; 1994 Dec 01; 8(12):2102-10. PubMed ID: 7807998
    [Abstract] [Full Text] [Related]

  • 4. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
    Yin CC, Medeiros LJ, Abruzzo LV, Jones D, Farhood AI, Thomazy VA.
    Am J Clin Pathol; 2005 Feb 01; 123(2):222-8. PubMed ID: 15842046
    [Abstract] [Full Text] [Related]

  • 5. All-trans retinoic acid induces Thrombospondin-1 expression in acute promyelocytic leukemia cells though down-regulation of its transcription repressor, c-MYC oncoprotein.
    Xu B, Liu P, Li J, Lu H.
    Biochem Biophys Res Commun; 2009 May 15; 382(4):790-4. PubMed ID: 19324018
    [Abstract] [Full Text] [Related]

  • 6. Macrophages and abnormal BCL-6 or c-MYC gene expression affect the resistance of peritoneal B cells to induction of hyporesponsiveness.
    Liou LB, Wu MW, Chao WJ.
    Scand J Immunol; 2009 May 15; 69(5):447-56. PubMed ID: 19508376
    [Abstract] [Full Text] [Related]

  • 7. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins.
    Li H, Xie P, Li G, Hao L, Xiong Q.
    Toxicon; 2009 Jan 15; 53(1):169-75. PubMed ID: 19041662
    [Abstract] [Full Text] [Related]

  • 8. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
    Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Bauml G, Rucker O, Schwarzmann F, Wolf H, Minarovits J.
    Med Sci Monit; 2003 Jan 15; 9(1):HY1-9. PubMed ID: 12552250
    [Abstract] [Full Text] [Related]

  • 9. Antisense regulation of expression and transactivation functions of the tumorigenic HBx and c-myc genes.
    Hung L, Kumar V.
    Biochem Biophys Res Commun; 2006 May 26; 344(1):293-9. PubMed ID: 16616001
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus-infected marmoset cells transfected with c-myc do not form lymphomas in mice with severe combined immunodeficiency.
    Salimi B, O'Gorman MR, Variakojis D, Bendet M, Newman M, Poupko E, Katz BZ.
    Mol Genet Metab; 1998 Jul 26; 64(3):205-12. PubMed ID: 9719630
    [Abstract] [Full Text] [Related]

  • 11. c-MYC impairs immunogenicity of human B cells.
    Schlee M, Schuhmacher M, Hölzel M, Laux G, Bornkamm GW.
    Adv Cancer Res; 2007 Jul 26; 97():167-88. PubMed ID: 17419945
    [Abstract] [Full Text] [Related]

  • 12. Regulation by c-Myc of ncRNA expression.
    Kenneth NS, White RJ.
    Curr Opin Genet Dev; 2009 Feb 26; 19(1):38-43. PubMed ID: 19179065
    [Abstract] [Full Text] [Related]

  • 13. MIF loss impairs Myc-induced lymphomagenesis.
    Talos F, Mena P, Fingerle-Rowson G, Moll U, Petrenko O.
    Cell Death Differ; 2005 Oct 26; 12(10):1319-28. PubMed ID: 15947793
    [Abstract] [Full Text] [Related]

  • 14. Defining the specific physiological requirements for c-Myc in T cell development.
    Douglas NC, Jacobs H, Bothwell AL, Hayday AC.
    Nat Immunol; 2001 Apr 26; 2(4):307-15. PubMed ID: 11276201
    [Abstract] [Full Text] [Related]

  • 15. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
    Tiniakos D, Spandidos DA, Yiagnisis M, Tiniakos G.
    Hepatogastroenterology; 1993 Feb 26; 40(1):37-40. PubMed ID: 8462926
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells.
    Awwad RT, Do K, Stevenson H, Fu SW, Lo-Coco F, Costello M, Campbell CL, Berg PE.
    Ann Hematol; 2008 Mar 26; 87(3):195-203. PubMed ID: 18026954
    [Abstract] [Full Text] [Related]

  • 17. Cancer: An unexpected addiction.
    Shaughnessy JD.
    Nature; 2008 Jul 10; 454(7201):172-3. PubMed ID: 18615074
    [No Abstract] [Full Text] [Related]

  • 18. Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases.
    Srimatkandada P, Loomis R, Carbone R, Srimatkandada S, Lacy J.
    Eur J Haematol; 2008 May 10; 80(5):407-18. PubMed ID: 18221384
    [Abstract] [Full Text] [Related]

  • 19. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML, Swinnen LJ, Plaisance KT, Schnell C, Grogan TM, Schneider BG, Southwest Oncology Group.
    Transplantation; 2003 Sep 27; 76(6):959-64. PubMed ID: 14508361
    [Abstract] [Full Text] [Related]

  • 20. Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translation.
    Mezquita P, Parghi SS, Brandvold KA, Ruddell A.
    Oncogene; 2005 Jan 27; 24(5):889-901. PubMed ID: 15580293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.